开云app官网登录入口网页版-官方正版

#头颈部#

163篇内容 | 2780人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1491907, encodeId=959f149190e02, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=European Radiology：头颈部单能量和双能量CT图像质量的比较, objectType=article, longId=738563, objectId=78f1e3856348, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78f1e3856348, replyNumber=0, likeNumber=76, createdTime=2022-09-09, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78f1e3856348, moduleTitle=European Radiology：头颈部单能量和双能量CT图像质量的比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=78f1e3856348)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491908, encodeId=44df149190882, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Braz J Otorhinolaryngol：头颈部皮肤鳞状细胞癌和基底细胞癌的细胞动力学标志物, objectType=article, longId=738416, objectId=a32de3841614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a32de3841614, replyNumber=0, likeNumber=93, createdTime=2022-09-08, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a32de3841614, moduleTitle=Braz J Otorhinolaryngol：头颈部皮肤鳞状细胞癌和基底细胞癌的细胞动力学标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a32de3841614)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491906, encodeId=05301491906f2, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=局部晚期头颈部癌症也可治愈！微创手术、质子、免疫、光免疫疗法提高治愈可能！, objectType=article, longId=735536, objectId=90a4e3553666, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a4e3553666, replyNumber=0, likeNumber=86, createdTime=2022-08-12, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a4e3553666, moduleTitle=局部晚期头颈部癌症也可治愈！微创手术、质子、免疫、光免疫疗法提高治愈可能！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=90a4e3553666)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491905, encodeId=a78b149190591, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=European Radiology：用于预测头颈部鳞状细胞癌程序性死亡配体1表达的放射组学特征, objectType=article, longId=733158, objectId=a796e33158c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a796e33158c0, replyNumber=0, likeNumber=90, createdTime=2022-07-26, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a796e33158c0, moduleTitle=European Radiology：用于预测头颈部鳞状细胞癌程序性死亡配体1表达的放射组学特征, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a796e33158c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491904, encodeId=c02114919049c, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=CCR：突破局部晚期治疗瓶颈！武汉协和医院MDT头颈部肿瘤成果刷新国际记录，晚期肿瘤治疗有效率达96%, objectType=article, longId=732387, objectId=f8fee323876e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8fee323876e, replyNumber=0, likeNumber=96, createdTime=2022-07-15, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8fee323876e, moduleTitle=CCR：突破局部晚期治疗瓶颈！武汉协和医院MDT头颈部肿瘤成果刷新国际记录，晚期肿瘤治疗有效率达96%, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f8fee323876e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491903, encodeId=6e29149190315, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Clin Cancer Res：局部晚期头颈部鳞状细胞癌的新辅助化疗+免疫治疗, objectType=article, longId=731133, objectId=8c55e311334c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c55e311334c, replyNumber=0, likeNumber=91, createdTime=2022-07-04, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c55e311334c, moduleTitle=Clin Cancer Res：局部晚期头颈部鳞状细胞癌的新辅助化疗+免疫治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8c55e311334c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491902, encodeId=de83149190201, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=APS：驱虫药帕苯达唑可治疗头颈部鳞状细胞癌, objectType=article, longId=730392, objectId=cf25e3039276, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf25e3039276, replyNumber=0, likeNumber=82, createdTime=2022-06-26, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf25e3039276, moduleTitle=APS：驱虫药帕苯达唑可治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf25e3039276)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491901, encodeId=645a14919015a, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=JGGD:头颈部基底细胞癌的皮镜手术对缩小切缘的研究, objectType=article, longId=730108, objectId=e6dee3010842, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6dee3010842, replyNumber=0, likeNumber=121, createdTime=2022-06-22, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6dee3010842, moduleTitle=JGGD:头颈部基底细胞癌的皮镜手术对缩小切缘的研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e6dee3010842)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491900, encodeId=d5b6149190052, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Clin Cancer Res：西妥昔单抗+纳武单抗联合治疗复发/转移性头颈部鳞癌, objectType=article, longId=723523, objectId=d89be23523ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d89be23523ff, replyNumber=0, likeNumber=109, createdTime=2022-04-06, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d89be23523ff, moduleTitle=Clin Cancer Res：西妥昔单抗+纳武单抗联合治疗复发/转移性头颈部鳞癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d89be23523ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491899, encodeId=99111491899b1, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=J Clin Oncol：采用派姆单抗±化疗治疗复发性/转移性头颈部鳞癌, objectType=article, longId=302189, objectId=e07a302189c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e07a302189c4, replyNumber=0, likeNumber=110, createdTime=2022-04-03, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e07a302189c4, moduleTitle=J Clin Oncol：采用派姆单抗±化疗治疗复发性/转移性头颈部鳞癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e07a302189c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491898, encodeId=117c1491898fb, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=一文读懂！头颈部CTA及头颈部血管常见变异, objectType=article, longId=300892, objectId=57e830089222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57e830089222, replyNumber=0, likeNumber=91, createdTime=2022-03-17, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e830089222, moduleTitle=一文读懂！头颈部CTA及头颈部血管常见变异, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=57e830089222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491897, encodeId=36e3149189e88, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效, objectType=article, longId=300287, objectId=836930028e24, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=836930028e24, replyNumber=0, likeNumber=72, createdTime=2022-03-10, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=836930028e24, moduleTitle=Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=836930028e24)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491896, encodeId=9db51491896bb, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Oncologist：CheckMate 141亚组分析比较nivolumab（那武利尤单抗）和化疗治疗复发或转移性头颈部鳞状细胞癌（R/M SCCHN）患者的疗效, objectType=article, longId=299383, objectId=8ef92993836d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ef92993836d, replyNumber=0, likeNumber=77, createdTime=2022-02-23, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ef92993836d, moduleTitle=Oncologist：CheckMate 141亚组分析比较nivolumab（那武利尤单抗）和化疗治疗复发或转移性头颈部鳞状细胞癌（R/M SCCHN）患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8ef92993836d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491895, encodeId=dd1614918956a, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Clin Cancer Res：纳武单抗+Lirilumab辅助治疗复发性头颈部鳞状细胞癌, objectType=article, longId=295065, objectId=466a295065dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=466a295065dc, replyNumber=0, likeNumber=90, createdTime=2022-02-04, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=466a295065dc, moduleTitle=Clin Cancer Res：纳武单抗+Lirilumab辅助治疗复发性头颈部鳞状细胞癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=466a295065dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491894, encodeId=6192149189461, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效, objectType=article, longId=295059, objectId=afe5295059f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe5295059f2, replyNumber=0, likeNumber=0, createdTime=2022-02-04, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe5295059f2, moduleTitle=Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=afe5295059f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491893, encodeId=89db149189317, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Clin Cancer Res：术前和术后应用nivolumab和lirilumab治疗局部区域复发的头颈部鳞状细胞癌(SCCHN)患者的疗效和安全性, objectType=article, longId=221221, objectId=5f1d221221eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f1d221221eb, replyNumber=0, likeNumber=72, createdTime=2021-11-30, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f1d221221eb, moduleTitle=Clin Cancer Res：术前和术后应用nivolumab和lirilumab治疗局部区域复发的头颈部鳞状细胞癌(SCCHN)患者的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5f1d221221eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491892, encodeId=94ac149189299, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=全面的图解头颈部血管解剖及Willis环常见变异, objectType=article, longId=220365, objectId=1c2422036526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c2422036526, replyNumber=0, likeNumber=142, createdTime=2021-11-16, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c2422036526, moduleTitle=全面的图解头颈部血管解剖及Willis环常见变异, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1c2422036526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491891, encodeId=3ed614918912b, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Front Oncol：每周PCC方案（紫杉醇+卡铂+西妥昔单抗）可用于不适合EXTREME方案治疗复发和/或转移性头颈部鳞状细胞癌（R/M-HNSCC）患者, objectType=article, longId=219629, objectId=09d321962921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09d321962921, replyNumber=0, likeNumber=67, createdTime=2021-11-03, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09d321962921, moduleTitle=Front Oncol：每周PCC方案（紫杉醇+卡铂+西妥昔单抗）可用于不适合EXTREME方案治疗复发和/或转移性头颈部鳞状细胞癌（R/M-HNSCC）患者, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=09d321962921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491890, encodeId=2a25149189031, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低, objectType=article, longId=217603, objectId=e41921e6037a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e41921e6037a, replyNumber=0, likeNumber=89, createdTime=2021-09-26, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e41921e6037a, moduleTitle=JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e41921e6037a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491889, encodeId=3382149188922, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性, objectType=article, longId=217545, objectId=e09321e54552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e09321e54552, replyNumber=0, likeNumber=0, createdTime=2021-09-25, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e09321e54552, moduleTitle=Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e09321e54552)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

头颈部

2020-05-29

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

European Radiology：头颈部单能量和双能量CT图像质量的比较

2022-09-09

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Braz J Otorhinolaryngol：头颈部皮肤鳞状细胞癌和基底细胞癌的细胞动力学标志物

2022-09-08

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

局部晚期头颈部癌症也可治愈！微创手术、质子、免疫、光免疫疗法提高治愈可能！

2022-08-12

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

European Radiology：用于预测头颈部鳞状细胞癌程序性死亡配体1表达的放射组学特征

2022-07-26

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

CCR：突破局部晚期治疗瓶颈！武汉协和医院MDT头颈部肿瘤成果刷新国际记录，晚期肿瘤治疗有效率达96%

2022-07-15

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Clin Cancer Res：局部晚期头颈部鳞状细胞癌的新辅助化疗+免疫治疗

2022-07-04

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

APS：驱虫药帕苯达唑可治疗头颈部鳞状细胞癌

2022-06-26

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

JGGD:头颈部基底细胞癌的皮镜手术对缩小切缘的研究

2022-06-22

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Clin Cancer Res：西妥昔单抗+纳武单抗联合治疗复发/转移性头颈部鳞癌

2022-04-06

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

J Clin Oncol：采用派姆单抗±化疗治疗复发性/转移性头颈部鳞癌

2022-04-03

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

一文读懂！头颈部CTA及头颈部血管常见变异

2022-03-17

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效

2022-03-10

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Oncologist：CheckMate 141亚组分析比较nivolumab（那武利尤单抗）和化疗治疗复发或转移性头颈部鳞状细胞癌（R/M SCCHN）患者的疗效

2022-02-23

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Clin Cancer Res：纳武单抗+Lirilumab辅助治疗复发性头颈部鳞状细胞癌

2022-02-04

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效

2022-02-04

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Clin Cancer Res：术前和术后应用nivolumab和lirilumab治疗局部区域复发的头颈部鳞状细胞癌(SCCHN)患者的疗效和安全性

2021-11-30

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

全面的图解头颈部血管解剖及Willis环常见变异

2021-11-16

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Front Oncol：每周PCC方案（紫杉醇+卡铂+西妥昔单抗）可用于不适合EXTREME方案治疗复发和/或转移性头颈部鳞状细胞癌（R/M-HNSCC）患者

2021-11-03

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低

2021-09-26

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性

2021-09-25

科室
- - 订阅+
  - 更多科室
工具
服务